XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Related-Party Transactions | 9 Months Ended
--- | ---
Sep. 30, 2022
Related Party Transactions [Abstract] |
Related-Party Transactions | Related-Party Transactions During the three and nine months ended September 30, 2022 and 2021, NMM recognized approximately $4.8 million and $4.5 million, respectively, and $15.9 million and $13.2 million, respectively, in management fees from LMA. LMA is accounted for under the equity method based on the 25% equity ownership interest held by APC in LMA’s IPA line of business (see Note 5 — “Investments in Other Entities - Equity Method”). APC and PMIOC have an Ancillary Service Contract together whereby PMIOC provides covered services on behalf of APC to enrollees of the plans of APC. During the three and nine months ended September 30, 2022 and 2021, APC paid approximately $0.7 million and $0.7 million, respectively, and $2.0 million and $1.7 million, respectively, to PMIOC for provider services, which is accounted for under the equity method based on the 40% equity ownership interest held by APC (see Note 5 — “Investments in Other Entities — Equity Method”). During the three and nine months ended September 30, 2021, APC paid $2.2 million and $5.4 million, respectively, to DMG for provider services, which is accounted for under the equity method based on the 40% equity ownership interest held by APC. In October 2021, DMG was consolidated by Apollo. As such, DMG is no longer a related party. During the three and nine months ended September 30, 2022 and 2021, APC paid approximately $0.1 million and $0.3 million, respectively, and $0.3 million and $0.4 million to Advanced Diagnostic Surgery Center for services as a provider. Advanced Diagnostic Surgery Center shares common ownership with certain board members of APC. During the three and nine months ended September 30, 2022 and 2021, APC paid approximately $0.2 million and $0.7 million, respectively, and $0.5 million and $1.1 million, respectively, to Fulgent Genetics, Inc. for services as a provider. One of the Company’s board members is a board member of Fulgent Genetics, Inc. During the three months ended September 30, 2022 and 2021, APC paid an aggregate of approximately $14.2 million and $10.1 million to shareholders, respectively, which included approximately $5.8 million and $1.8 million, respectively, to shareholders who are also officers of APC. During the nine months ended September 30, 2022 and 2021, APC paid an aggregate of approximately $35.3 million and $25.3 million to shareholders, respectively, and $11.0 million and $5.6 million, respectively, to shareholders who are also officers of APC. For the three and nine months ended September 30, 2022 and 2021, SCHC paid approximately $0.1 million and $0.1 million, respectively, and $0.3 million and $0.3 million, respectively, to Numen, LLC (“Numen”) for an office lease. Numen is owned by a shareholder of APC. During the three and nine ended September 30, 2022 and 2021, NMM paid approximately $0.4 million and $0.4 million, respectively, and $1.1 million and $1.1 million, respectively, to One MSO for an office lease, which is accounted for under the equity method based on 50% equity ownership interest held by APC (see Note 5 — “Investments in Other Entities — Equity Method”). During the three and nine months ended September 30, 2022 and 2021, APC paid approximately $4.0 million and $3.6 million, respectively, and $11.3 million and to $10.5 million, respectively, to Arroyo Vista Family Health Center (“Arroyo Vista”) for services as a provider. Arroyo Vista’s chief executive officer is a member of the Company’s board of directors. The Company has agreements with Health Source MSO Inc., a California corporation (“HSMSO”), Aurion Corporation (“Aurion”), and AHMC for services provided to the Company. One of the Company’s board members is an officer of AHMC, HSMSO, and Aurion. Aurion is also partially owned by one of the Company’s board members. The following table sets forth fees incurred and income received related to AHMC, HSMSO, and Aurion (in thousands):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
AHMC – Risk pool, capitation, claims payment | $ | 13,532 |  |  | $ | 10,712 |  |  | $ | 39,317 |  |  | $ | 36,505 |
HSMSO – Management fees, net | (395) |  |  | (33) |  |  | (1,123) |  |  | (141) |
Aurion – Management fees | (75) |  |  | (100) |  |  | (225) |  |  | (252) |
Receipts, net | $ | 13,062 |  |  | $ | 10,579 |  |  | $ | 37,969 |  |  | $ | 36,112 |
The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. During the three and nine months ended September 30, 2022 and 2021, the Company has recognized risk pool revenue under this agreement of $13.6 million and $21.5 million, and $38.9 million and $47.1 million, respectfully, of which $85.2 million and $58.4 million remained outstanding as of September 30, 2022 and December 31, 2021, respectively. During the three and nine months ended September 30, 2022, APC paid $0 and $9.3 million, respectively, to purchase Apollo’s stock from a board member. In addition, affiliates wholly owned by the Company’s officers, including Dr. Thomas Lam, ApolloMed’s Co-CEO and President, are reported in the accompanying consolidated statements of operations on a consolidated basis, together with the Company’s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company’s subsidiaries as related-party transactions. For equity method investments and loans receivable from related parties, see Note 5 — “Investment in Other Entities — Equity Method” and Note 6 — “Loan Receivable and Loan Receivable — Related Parties”, respectively.

X
- References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -URI https://asc.fasb.org/topic&trid=2122745 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864 + Details
Name: | us-gaap_RelatedPartyTransactionsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration